No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / genetics
-
Adenocarcinoma / secondary
-
Adult
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / secondary
-
Brain Neoplasms / surgery
-
Combined Modality Therapy
-
Digestive System Surgical Procedures
-
Esophageal Neoplasms / drug therapy*
-
Esophageal Neoplasms / genetics
-
Esophageal Neoplasms / pathology
-
Esophagogastric Junction / pathology
-
Humans
-
Male
-
Receptor, ErbB-2 / genetics*
-
Salvage Therapy / methods
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / genetics
-
Stomach Neoplasms / secondary
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab